Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India

R. Panigrahi, Shounak Majumder, M. Gooptu, A. Biswas, S. Datta, P. K. Chandra, A. Banerjee, S. Chakrabarti, D. Bandopadhyay, B. K. De, R. Chakravarty

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background. The prevalence of occult HBV, defined by the presence of HBV DNA in individuals with anti-bodies to HBV core antigen and with absence of HBV surface antigen, but its clinical significance and viro-logical features in HIV-infected patients is still unclear. Aim. To investigate the prevalence, clinical significance and molecular characterization of occult hepatitis B virus infection in ART-Naive HIV-positive individuals. Material and methods. Among the 1077 HIV-infected patients with different risk factors for HIV infection, 297 were HBsAg-ve ART-naive, of them 112 was randomly selected for the study. HBV DNA was tested by in-house PCR and quantified by qPCR. Molecular characterization was performed by sequencing the envelope and overlapping polymerase genes. Results. We found the prevalence of occult HBV to be 10.7% among a randomly selected group of HBsAg-ve/antiHBc+ve HIV-infected patients. Overall 33.9% (38 of 112) of the patients were antiHBc positive indicating exposure to HBV infection. HBV DNA was detected in 12/38 (31.5%) antiHBc positive samples and 50% of them had CD4 T cell count < 200 cells/mm3. HCV coinfec-tion was low (2.7%). No surrogate marker for OBI could be identified. Presence of antiHBs antibodies did not rule out OBI. Liver biopsy in six cases showed varying stages of chronic hepatitis. Several mutations were detected but not the common immune escape mutant G145R. Conclusion. In conclusion the preva-lence of OBI was significantly high among HIV coinfected patients, which highlights the importance of HBV DNA testing in these patients and indicates need for further prospective studies in larger cohorts to assess its clinical significance.

Original languageEnglish (US)
Pages (from-to)870-875
Number of pages6
JournalAnnals of Hepatology
Volume11
Issue number6
StatePublished - Nov 26 2012
Externally publishedYes

Fingerprint

India
Referral and Consultation
HIV
Infection
DNA
Hepatitis B Surface Antigens
Overlapping Genes
Virus Diseases
Chronic Hepatitis
Surface Antigens
CD4 Lymphocyte Count
Hepatitis B virus
HIV Infections
Biomarkers
Prospective Studies
T-Lymphocytes
Biopsy
Antigens
Polymerase Chain Reaction
Mutation

Keywords

  • Antibodies to HBV core antigen
  • ART naïve
  • HBV DNA
  • OBI

ASJC Scopus subject areas

  • Hepatology

Cite this

Panigrahi, R., Majumder, S., Gooptu, M., Biswas, A., Datta, S., Chandra, P. K., ... Chakravarty, R. (2012). Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India. Annals of Hepatology, 11(6), 870-875.

Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India. / Panigrahi, R.; Majumder, Shounak; Gooptu, M.; Biswas, A.; Datta, S.; Chandra, P. K.; Banerjee, A.; Chakrabarti, S.; Bandopadhyay, D.; De, B. K.; Chakravarty, R.

In: Annals of Hepatology, Vol. 11, No. 6, 26.11.2012, p. 870-875.

Research output: Contribution to journalArticle

Panigrahi, R, Majumder, S, Gooptu, M, Biswas, A, Datta, S, Chandra, PK, Banerjee, A, Chakrabarti, S, Bandopadhyay, D, De, BK & Chakravarty, R 2012, 'Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India', Annals of Hepatology, vol. 11, no. 6, pp. 870-875.
Panigrahi, R. ; Majumder, Shounak ; Gooptu, M. ; Biswas, A. ; Datta, S. ; Chandra, P. K. ; Banerjee, A. ; Chakrabarti, S. ; Bandopadhyay, D. ; De, B. K. ; Chakravarty, R. / Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India. In: Annals of Hepatology. 2012 ; Vol. 11, No. 6. pp. 870-875.
@article{3c70d1cbe4b84c10a780be7082d38669,
title = "Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India",
abstract = "Background. The prevalence of occult HBV, defined by the presence of HBV DNA in individuals with anti-bodies to HBV core antigen and with absence of HBV surface antigen, but its clinical significance and viro-logical features in HIV-infected patients is still unclear. Aim. To investigate the prevalence, clinical significance and molecular characterization of occult hepatitis B virus infection in ART-Naive HIV-positive individuals. Material and methods. Among the 1077 HIV-infected patients with different risk factors for HIV infection, 297 were HBsAg-ve ART-naive, of them 112 was randomly selected for the study. HBV DNA was tested by in-house PCR and quantified by qPCR. Molecular characterization was performed by sequencing the envelope and overlapping polymerase genes. Results. We found the prevalence of occult HBV to be 10.7{\%} among a randomly selected group of HBsAg-ve/antiHBc+ve HIV-infected patients. Overall 33.9{\%} (38 of 112) of the patients were antiHBc positive indicating exposure to HBV infection. HBV DNA was detected in 12/38 (31.5{\%}) antiHBc positive samples and 50{\%} of them had CD4 T cell count < 200 cells/mm3. HCV coinfec-tion was low (2.7{\%}). No surrogate marker for OBI could be identified. Presence of antiHBs antibodies did not rule out OBI. Liver biopsy in six cases showed varying stages of chronic hepatitis. Several mutations were detected but not the common immune escape mutant G145R. Conclusion. In conclusion the preva-lence of OBI was significantly high among HIV coinfected patients, which highlights the importance of HBV DNA testing in these patients and indicates need for further prospective studies in larger cohorts to assess its clinical significance.",
keywords = "Antibodies to HBV core antigen, ART na{\"i}ve, HBV DNA, OBI",
author = "R. Panigrahi and Shounak Majumder and M. Gooptu and A. Biswas and S. Datta and Chandra, {P. K.} and A. Banerjee and S. Chakrabarti and D. Bandopadhyay and De, {B. K.} and R. Chakravarty",
year = "2012",
month = "11",
day = "26",
language = "English (US)",
volume = "11",
pages = "870--875",
journal = "Annals of Hepatology",
issn = "1665-2681",
publisher = "Mexican Association of Hepatology",
number = "6",

}

TY - JOUR

T1 - Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India

AU - Panigrahi, R.

AU - Majumder, Shounak

AU - Gooptu, M.

AU - Biswas, A.

AU - Datta, S.

AU - Chandra, P. K.

AU - Banerjee, A.

AU - Chakrabarti, S.

AU - Bandopadhyay, D.

AU - De, B. K.

AU - Chakravarty, R.

PY - 2012/11/26

Y1 - 2012/11/26

N2 - Background. The prevalence of occult HBV, defined by the presence of HBV DNA in individuals with anti-bodies to HBV core antigen and with absence of HBV surface antigen, but its clinical significance and viro-logical features in HIV-infected patients is still unclear. Aim. To investigate the prevalence, clinical significance and molecular characterization of occult hepatitis B virus infection in ART-Naive HIV-positive individuals. Material and methods. Among the 1077 HIV-infected patients with different risk factors for HIV infection, 297 were HBsAg-ve ART-naive, of them 112 was randomly selected for the study. HBV DNA was tested by in-house PCR and quantified by qPCR. Molecular characterization was performed by sequencing the envelope and overlapping polymerase genes. Results. We found the prevalence of occult HBV to be 10.7% among a randomly selected group of HBsAg-ve/antiHBc+ve HIV-infected patients. Overall 33.9% (38 of 112) of the patients were antiHBc positive indicating exposure to HBV infection. HBV DNA was detected in 12/38 (31.5%) antiHBc positive samples and 50% of them had CD4 T cell count < 200 cells/mm3. HCV coinfec-tion was low (2.7%). No surrogate marker for OBI could be identified. Presence of antiHBs antibodies did not rule out OBI. Liver biopsy in six cases showed varying stages of chronic hepatitis. Several mutations were detected but not the common immune escape mutant G145R. Conclusion. In conclusion the preva-lence of OBI was significantly high among HIV coinfected patients, which highlights the importance of HBV DNA testing in these patients and indicates need for further prospective studies in larger cohorts to assess its clinical significance.

AB - Background. The prevalence of occult HBV, defined by the presence of HBV DNA in individuals with anti-bodies to HBV core antigen and with absence of HBV surface antigen, but its clinical significance and viro-logical features in HIV-infected patients is still unclear. Aim. To investigate the prevalence, clinical significance and molecular characterization of occult hepatitis B virus infection in ART-Naive HIV-positive individuals. Material and methods. Among the 1077 HIV-infected patients with different risk factors for HIV infection, 297 were HBsAg-ve ART-naive, of them 112 was randomly selected for the study. HBV DNA was tested by in-house PCR and quantified by qPCR. Molecular characterization was performed by sequencing the envelope and overlapping polymerase genes. Results. We found the prevalence of occult HBV to be 10.7% among a randomly selected group of HBsAg-ve/antiHBc+ve HIV-infected patients. Overall 33.9% (38 of 112) of the patients were antiHBc positive indicating exposure to HBV infection. HBV DNA was detected in 12/38 (31.5%) antiHBc positive samples and 50% of them had CD4 T cell count < 200 cells/mm3. HCV coinfec-tion was low (2.7%). No surrogate marker for OBI could be identified. Presence of antiHBs antibodies did not rule out OBI. Liver biopsy in six cases showed varying stages of chronic hepatitis. Several mutations were detected but not the common immune escape mutant G145R. Conclusion. In conclusion the preva-lence of OBI was significantly high among HIV coinfected patients, which highlights the importance of HBV DNA testing in these patients and indicates need for further prospective studies in larger cohorts to assess its clinical significance.

KW - Antibodies to HBV core antigen

KW - ART naïve

KW - HBV DNA

KW - OBI

UR - http://www.scopus.com/inward/record.url?scp=84869447714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869447714&partnerID=8YFLogxK

M3 - Article

C2 - 23109450

AN - SCOPUS:84869447714

VL - 11

SP - 870

EP - 875

JO - Annals of Hepatology

JF - Annals of Hepatology

SN - 1665-2681

IS - 6

ER -